1. NEONATALTHROMBOCYTOPENIA By:Adrian B. Jayawon Ma. Joselle L. BalasaKatrina Kaye C. Bañas Nikki Marie O. BlancoKarleen T. Buenasflores 2. Thrombocytopenia• Defined as…

1. NEONATALTHROMBOCYTOPENIA By:Adrian B. Jayawon Ma. Joselle L. BalasaKatrina Kaye C. Bañas Nikki Marie O. BlancoKarleen T. Buenasflores 2. Thrombocytopenia• Defined as…

1. INTERPRETATION OF LAB TESTS with a Pharmaceutical FocusBarb Bancroft, RN, MSN, PNPChicago, [email protected] 5, 2010 2. Rule number one …Know…

Slide 1Mechanism of Action of Antithrombotic Drugs Rabih R. Azar, MD, MSc, FACC Division of Cardiology Hotel Dieu de France Hospital Slide 2 Mechanism of Action of Antithrombotic…

1. INTERESTINGCASE OF BACK ACHEDR.ANIRUDH J SHETTY PROF.DR.G.ELANGOVAN’S UNIT 2. 24 year old female came with the complaints…

Zhijian Xiao, M.D. MDS and MPN Centre, Blood Diseases Hospital Chinese Academy of Medical Sciences Recent advances in treatment of MDS The IPSS (R) category provides a risk-based…

American Journal of Obstetrics and Gynecology (2006) 195, 914–34 James N. Martin Jr, MD, Carl H. Rose, MD, Christian M. Briery, MD Department of Obstetrics and Gynecology,…

Slide 1Suzanne Reuter MD SDPA 2014 Deadwood, SD Neonatal Thrombocytopenia Slide 2 Financial Disclosure I have no relevant financial relationships to disclose. Slide 3 Objectives…

Slide 1 Valvular Involvement in SLE Christopher G. Stephenson, MD, FACC The Sanger Clinic, PA Slide 2 Acknowlegements  Sreekanth Reddy, MD Hematology/Oncology Atlanta…

Slide 1 Thrombosis Update Tom DeLoughery MD FACP FAWM Oregon Health and Sciences University Slide 2 DISCLOSURE Current Relevant Financial Relationship(s) Speaker Bureau –…